
ES Cap 500mg Tablet
Marketer
Esperer Onco Nutrition Private Limited
Salt Composition
Capecitabine (500mg)
Overview ES Cap 500mg Tablet
Estrogen-sensitive Cap 500mg capsules are indicated for managing cancers affecting the breast, colon, or rectum. Additional applications may be prescribed by a physician. This medication, a component of chemotherapy, is administered alone or in conjunction with other drugs. Consume the 500mg capsule with food, within 30 minutes post-meal. Dosage and frequency are determined by your doctor, contingent upon your specific condition, and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdosage can lead to severe adverse effects. While therapeutic benefits may take weeks or months to manifest, discontinuation should only occur under medical supervision. Frequent side effects include nausea, vomiting, weakness, abdominal discomfort, and diarrhea. A decrease in white blood cells, increasing infection vulnerability, is possible. Regular blood tests are essential to monitor blood cell counts, along with liver, heart, and uric acid levels. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, or the use of any anti-infective medications. Potential drug interactions are numerous; inform your physician of all concurrent medications. Use during pregnancy or breastfeeding is contraindicated. Employing effective contraception by both partners throughout treatment is vital to prevent pregnancy.
Primary Ingredients of ES Cap 500mg Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of ES Cap 500mg Tablet
Carcinoma of the breast and colorectal cancer
Major Benefits of ES Cap 500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 500mg ES Cap tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of ES Cap 500mg Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use ES Cap 500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg ES Cap tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How ES Cap 500mg Tablet works:
ES Cap 500mg tablets function as an anti-neoplastic agent. Metabolic processes transform this medication into 5-fluorouracil, which inhibits the production of RNA and DNA within cancerous cells. This disruption of cellular genetic material synthesis impedes cancer cell proliferation, leading to their eventual destruction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside ES Cap 500mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using ES Cap 500mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the 500mg ES Cap Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking a 500mg ES Cap Tablet could reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using 500mg ES Cap tablets; dosage modification may be necessary. Consult a physician for guidance. 500mg ES Cap tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use 500mg ES Cap tablets cautiously, potentially requiring dosage modification under medical supervision. The use of 500mg ES Cap tablets is contraindicated in individuals with severe renal dysfunction.
What if you forget to take ES Cap 500mg Tablet :
NA
Facts to Know About ES Cap 500mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic Antagonists |
